Business Wire

eLichens Launches the First Modular & Connected Air Quality IoT Device for Indoor Wellbeing and Energy Efficiency

Del

eLichens, a leading designer of patented gas sensors and the first comprehensive air quality analysis and prediction platform today announces the release of its modular real time IAQ, Indoor Air Quality, connected device.

eLichens modular IoT device seeks an improved customer experience in an eco-aware context where Indoor one’s wellbeing meets energy efficiency, leading to unique user experience. In fact, the impact of air quality on health and life comfort is well established. In modern societies, people spend more than 80 percent of their time indoors. Therefore, indoor air quality monitoring is of great importance to human health. Concurrently, there is a growing challenge for innovative solutions that lay the foundation for more efficient indoor environment by developing energy-saving technologies.

To tackle these challenges, eLichens focused its effort to design and introduce a real-time modular IAQ solution that presents the advantage of a smart scalable system allowing seamless integration of various sensing technologies. The connected device is an end-to-end solution enabling measurement of CO₂ - Carbon Dioxide, PM - Particulate matter, VOC - Volatile Organic Compound, ambient temperature, light, relative humidity and level of noise (additional sensors are optional: NO₂ - Nitrogen Dioxide, O₃ - Ozone and CH2O - Formaldehyde).

Using encrypted wireless sensor networks, the IAQ solution can be linked to local gateway to connect to the external world for ubiquitous access of data.

eLichens IAQ device offers the advantage of being battery operated, auto-calibrated with drift compensated versus aging, temperature & humidity with no maintenance or post intervention needed.

This device takes full control of the ventilation system and any other Smart Home/Building connected IoT devices. It interfaces with eLichens patented hyper local outdoor air quality services (10 meters precision at street level) allowing smart & optimized energy efficiency.

"We have worked hand in hand with Daikin to introduce a real time connected Indoor Air Quality device that takes advantage of the eLichens CO2 NDIR patented, auto-calibrated, ultra-low power (<< 0.1mW) and high performances sensor, and the deep expertise of Daikin in energy efficiency for air conditioning and ventilation systems. This partnership resulted in a much needed and industrial expert IoT solution,” said Wahid Issa, chief executive officer of eLichens.

We have been excited working with eLichens engineers where the specification of this complete system on device meet Daikin requirements, and could become a powerful tool for indoor environment control,” said Dr. Piao, President, Daikin Open Innovation Lab Silicon Valley.

About eLichens ( www.eLichens.com )

Created in December 2014, eLichens is a start-up with a mission to help individuals digitize their environment. The company relies on a portfolio of patents, know-how and skills which enable it to develop and market complete sensor and data services solutions to address the industrial, smart home, smart city and consumer markets.

eLichens has its headquarters in Grenoble and offices in California.

About Daikin ( www.daikin.com )

Daikin has been a global leader in the air conditioning industry for over 90 years.

Our products are sold in over 140 countries and have innovation centers around the globe. Today, we are extending our reach to Silicon Valley to collaborate with some of the brightest minds in new technology to create the clean air solutions of tomorrow and help deliver real change by building a more sustainable, comfortable and healthier society that elevates our quality of life.

Contact information

eLichens
Wahid Issa
press@elichens.com
or
Daikin
Shintaro Imoto
shintaro.imoto@dsv.daikin.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 07:58Pressemelding

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs